Subscribe to RSS
DOI: 10.1055/s-2005-871575
A Review of Advances in the Synthesis of Analogues of the Delphinium Alkaloid Methyllycaconitine
Publication History
Received
22 February 2005
Publication Date:
22 June 2005 (online)


Abstract
Neuronal nicotinic acetylcholine receptors of the α7 sub-type are potential targets for drug development in the treatment of Alzheimer’s disease. The Delphinium alkaloid methyllycaconitine is a potent and selective α7 sub-type selective nicotinic acetylcholine receptor antagonist. The total synthesis of this pharmacologically active alkaloid has not yet been achieved. A summary of semi-synthetic methods to prepare methyllycaconitine is presented. Existing synthetic strategies used to prepare E, AE, AEF, ABE, ABDE, ABEF ring analogues of methyllycaconitine are reviewed for the first time.
-
1 Introduction
-
1.1 Alzheimer’s Disease and α7 Nicotinic Acetylcholine Receptors
-
1.2 Methyllycaconitine - An α7 Subtype Selective Nicotinic Acetylcholine Receptor Antagonist
-
1.3 Structure-Activity Relationships of Delphinium Alkaloids
-
2 Semi-Syntheses of Delphinium Alkaloids
-
3 Synthesis of Analogues of Methyllycaconitine
-
3.1 Synthesis of E Ring Analogues of Methyllycaconitine
-
3.2 Synthesis of AE Ring Bicyclic Analogues of Methyllycaconitine
-
3.3 Synthesis of AEF Ring Tricyclic Analogues of Methyllycaconitine
-
3.4 Synthesis of ABE Ring Tricyclic Analogues of Methyllycaconitine
-
3.5 Synthesis of ABDE Ring Tetracyclic Analogues of Methyllycaconitine
-
3.6 Synthesis of ABEF Ring Tetracyclic Analogues of Methyllycaconitine
-
4 Conclusion
Key words
semi-synthesis - Delphinium alkaloids - nicotinic acetylcholine receptor α7 sub-type selective antagonists